Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference

Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference   NEW YORK – April 26, 2021 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other…